SDGR - Schrodinger, Inc.
13.03
-0.090 -0.691%
Share volume: 1,323,470
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$13.12
-0.09
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-01-2024 | 07-31-2024 | 11-12-2024 | 02-26-2025 | 05-07-2025 | 11-05-2025 | 02-25-2026 | |
| Assets | ||||||||
| Total Assets | 737.762 M | 688.371 M | 669.296 M | 823.226 M | 743.032 M | 653.660 M | 726.160 M | |
| Current Assets | 493.686 M | 449.179 M | 456.398 M | 634.993 M | 570.944 M | 471.722 M | 519.265 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 12.349 M | 15.493 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 12.349 M | 15.493 M | 228.263 M | 204.798 M | 174.301 M | 219.113 M | 164.947 M | |
| Total Receivables | 45.620 M | 52.170 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 431.079 M | 377.289 M | 160.416 M | 147.326 M | 325.997 M | 172.120 M | 230.517 M | |
| Total Non-current Assets | 244.076 M | 239.192 M | 65.216 M | 43.208 M | 30.113 M | 44.382 M | 73.647 M | |
| Property Plant Equipment | 26.133 M | 25.723 M | 24.922 M | 24.196 M | 22.937 M | 20.738 M | 19.456 M | |
| Other Assets | 3.187 M | 3.598 M | 187.976 M | 164.037 M | 149.151 M | 161.200 M | 187.439 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 4.791 M | 4.791 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 737.762 M | 688.371 M | 669.296 M | 823.226 M | 743.032 M | 653.660 M | 726.160 M | |
| Total liabilities | 224.056 M | 214.391 M | 219.871 M | 401.781 M | 369.528 M | 332.308 M | 362.107 M | |
| Total current liabilities | 106.507 M | 99.759 M | 111.117 M | 191.747 M | 165.472 M | 145.113 M | 189.136 M | |
| Accounts Payable | 9.974 M | 8.116 M | 11.210 M | 10.666 M | 11.861 M | 9.218 M | 11.452 M | |
| Other liabilities | 8.561 M | 7.504 M | 103.554 M | 101.220 M | 155.000 K | 94.805 M | 94.094 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 8.561 M | 7.504 M | 103.554 M | 101.220 M | 155.000 K | 94.805 M | 94.094 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 513.706 M | 473.980 M | 449.425 M | 421.445 M | 373.504 M | 321.352 M | 364.053 M | |
| Common stock | 72.291 M | 72.712 M | 934.153 M | 946.766 M | 958.763 M | 982.590 M | 992.752 M | |
| Retained earnings | -393.142 M | -447.189 M | -485.325 M | -525.541 M | -585.349 M | -661.317 M | -628.806 M |